A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada
Crossref DOI link: https://doi.org/10.1186/s12871-016-0281-3
Published Online: 2016-11-16
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Insinga, Ralph P.
Joyal, Cédric
Goyette, Alexandra
Galarneau, André
Funding for this research was provided by:
Merck (US)